TY - STD TI - World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Published January 30, 2020. Accessed 28 Mar 2020. UR - https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) ID - ref1 ER - TY - STD TI - World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020. Published March 11, 2020. Accessed 20 Mar 2020. UR - https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020 ID - ref2 ER - TY - STD TI - World Health Organization. WHO director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Published February 11, 2020. Accessed 28 Mar 2020. UR - https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 ID - ref3 ER - TY - JOUR AU - Fisher, D. AU - Wilder-Smith, A. PY - 2020 DA - 2020// TI - The global community needs to swiftly ramp up the response to contain COVID-19 JO - Lancet VL - S0140–6736 ID - Fisher2020 ER - TY - STD TI - Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China [published online ahead of print, 2020 Mar 13]. Jama Intern Med. 2020;180(7):934–43. ID - ref5 ER - TY - STD TI - Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review [published online ahead of print, 2020 Mar 27]. JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.1286. ID - ref6 ER - TY - STD TI - Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19 [published online ahead of print, 2020 Apr 17]. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14849. ID - ref7 ER - TY - STD TI - Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in COVID-19 Patients: Awareness of an increased prevalence [published online ahead of print, 2020 Apr 24]. Circulation. 2020. https://doi.org/10.1161/CIRCULATIONAHA.120.047430. ID - ref8 ER - TY - STD TI - Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China [published online ahead of print, 2020 Feb 28]. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032. ID - ref9 ER - TY - STD TI - Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response [published online ahead of print, 2020 Mar 13]. JAMA, 2020. https://doi.org/10.1001/jama.2020.4031. ID - ref10 ER - TY - JOUR AU - Huang, C. AU - Wang, Y. AU - Li, X. PY - 2020 DA - 2020// TI - Clinical features of patients infected with 2019 novel coronavirus in Wuhan JO - China Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30183-5 DO - 10.1016/S0140-6736(20)30183-5 ID - Huang2020 ER - TY - JOUR AU - Mehta, P. AU - McAuley, D. F. AU - Brown, M. PY - 2020 DA - 2020// TI - COVID-19: consider cytokine storm syndromes and immunosuppression JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30628-0 DO - 10.1016/S0140-6736(20)30628-0 ID - Mehta2020 ER - TY - STD TI - Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print, 2020 Mar 18]. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001282. ID - ref13 ER - TY - STD TI - Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - preliminary report [published online ahead of print, 2020 May 22]. N Engl J Med. 2020;NEJMoa2007764. https://doi.org/10.1056/NEJMoa2007764. ID - ref14 ER - TY - JOUR AU - Sheahan, T. P. AU - Sims, A. C. AU - Graham, R. L. PY - 2017 DA - 2017// TI - Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses JO - Sci Transl Med VL - 9 UR - https://doi.org/10.1126/scitranslmed.aal3653 DO - 10.1126/scitranslmed.aal3653 ID - Sheahan2017 ER - TY - JOUR AU - Wang, M. AU - Cao, R. AU - Zhang, L. PY - 2020 DA - 2020// TI - Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro JO - Cell Res VL - 30 UR - https://doi.org/10.1038/s41422-020-0282-0 DO - 10.1038/s41422-020-0282-0 ID - Wang2020 ER - TY - STD TI - Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19 [published online ahead of print, 2020 Mar 20]. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30127-2. ID - ref17 ER - TY - STD TI - Gattinoni L, et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive Care Med. 2020;46(6):1099–102. ID - ref18 ER - TY - STD TI - Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [published correction appears in Lancet Respir Med. 2020 Feb 25;:]. Lancet Respir Med 2020;8(4):420–422. ID - ref19 ER - TY - JOUR AU - Chu, D. K. AU - Kim, L. H. AU - Young, P. J. PY - 2018 DA - 2018// TI - Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30479-3 DO - 10.1016/S0140-6736(18)30479-3 ID - Chu2018 ER - TY - JOUR AU - Metlay, J. P. AU - Waterer, G. W. AU - Long, A. C. PY - 2019 DA - 2019// TI - Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America JO - Am J Respir Crit Care Med VL - 200 UR - https://doi.org/10.1164/rccm.201908-1581ST DO - 10.1164/rccm.201908-1581ST ID - Metlay2019 ER - TY - JOUR AU - Woodhead, M. AU - Blasi, F. AU - Ewig, S. PY - 2011 DA - 2011// TI - Guidelines for the management of adult lower respiratory tract infections--full version JO - Clin Microbiol Infect VL - 17 UR - https://doi.org/10.1111/j.1469-0691.2011.03672.x DO - 10.1111/j.1469-0691.2011.03672.x ID - Woodhead2011 ER - TY - JOUR AU - Cosentini, R. AU - Brambilla, A. M. AU - Aliberti, S. PY - 2010 DA - 2010// TI - Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial JO - Chest. VL - 138 UR - https://doi.org/10.1378/chest.09-2290 DO - 10.1378/chest.09-2290 ID - Cosentini2010 ER - TY - JOUR AU - Rochwerg, B. AU - Brochard, L. AU - Elliott, M. W. PY - 2017 DA - 2017// TI - Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure JO - Eur Respir J VL - 50 UR - https://doi.org/10.1183/13993003.02426-2016 DO - 10.1183/13993003.02426-2016 ID - Rochwerg2017 ER - TY - JOUR AU - Brochard, L. AU - Slutsky, A. AU - Pesenti, A. PY - 2017 DA - 2017// TI - Mechanical ventilation to minimize progression of lung injury in acute respiratory failure JO - Am J Respir Crit Care Med VL - 195 UR - https://doi.org/10.1164/rccm.201605-1081CP DO - 10.1164/rccm.201605-1081CP ID - Brochard2017 ER - TY - STD TI - Pan C, Chen L, Lu C, et al. Lung Recruitability in SARS-CoV-2 Associated Acute Respiratory Distress Syndrome: A Single-center, Observational Study [published online ahead of print, 2020 Mar 23]. Am J Respir Crit Care Med. 2020. https://doi.org/10.1164/rccm.202003-0527LE. ID - ref26 ER - TY - JOUR AU - Paolini, V. AU - Faverio, P. AU - Aliberti, S. PY - 2018 DA - 2018// TI - Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: do we need a personalized approach? JO - PeerJ. VL - 6 UR - https://doi.org/10.7717/peerj.4211 DO - 10.7717/peerj.4211 ID - Paolini2018 ER - TY - JOUR AU - Ding, L. AU - Wang, L. AU - Ma, W. AU - He, H. PY - 2020 DA - 2020// TI - Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study JO - Crit Care VL - 24 UR - https://doi.org/10.1186/s13054-020-2738-5 DO - 10.1186/s13054-020-2738-5 ID - Ding2020 ER - TY - JOUR AU - Pérez-Nieto, O. R. AU - Guerrero-Gutiérrez, M. A. AU - Deloya-Tomas, E. AU - Ñamendys-Silva, S. A. PY - 2020 DA - 2020// TI - Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS JO - Crit Care VL - 24 UR - https://doi.org/10.1186/s13054-020-2821-y DO - 10.1186/s13054-020-2821-y ID - Pérez-Nieto2020 ER - TY - JOUR AU - Caputo, N. D. AU - Strayer, R. J. AU - Levitan, R. PY - 2020 DA - 2020// TI - Early self-proning in awake, non-intubated patients in the emergency department: a single ED's experience during the COVID-19 pandemic JO - Acad Emerg Med VL - 27 UR - https://doi.org/10.1111/acem.13994 DO - 10.1111/acem.13994 ID - Caputo2020 ER - TY - JOUR AU - Gattinoni, L. AU - Protti, A. PY - 2008 DA - 2008// TI - Ventilation in the prone position: for some but not for all? JO - CMAJ VL - 178 UR - https://doi.org/10.1503/cmaj.080359 DO - 10.1503/cmaj.080359 ID - Gattinoni2008 ER - TY - STD TI - Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. Covid-19 does not lead to a “typical” acute respiratory distress syndrome [published online ahead of print, 2020 Mar 30]. Am J Respir Crit Care Med. 2020. https://doi.org/10.1164/rccm.202003-0817LE. ID - ref32 ER - TY - STD TI - Simonds AK, Hanak A, Chatwin M, et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess (Winchester, England). 2010;14(131):–72. ID - ref33 ER - TY - JOUR AU - Ferioli, M. AU - Cisternino, C. AU - Leo, V. PY - 2020 DA - 2020// TI - Protecting healthcare workers from SARS-CoV-2 infection: practical indications JO - Eur Respir Rev VL - 29 UR - https://doi.org/10.1183/16000617.0068-2020 DO - 10.1183/16000617.0068-2020 ID - Ferioli2020 ER - TY - STD TI - Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents. 2020;56(1):105949. ID - ref35 ER - TY - JOUR AU - Arshad, S. AU - Kilgore, P. AU - Chaudhry, Z. S. PY - 2020 DA - 2020// TI - Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 JO - Int J Infect Dis VL - 97 UR - https://doi.org/10.1016/j.ijid.2020.06.099 DO - 10.1016/j.ijid.2020.06.099 ID - Arshad2020 ER - TY - STD TI - Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [published online ahead of print, 2020 Mar 9]. Clin Infect Dis. 2020;71(15):732–9. ID - ref37 ER - TY - JOUR AU - Liu, J. AU - Cao, R. AU - Xu, M. AU - Wang, X. PY - 2020 DA - 2020// TI - Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro JO - Cell Discov VL - 6 UR - https://doi.org/10.1038/s41421-020-0156-0 DO - 10.1038/s41421-020-0156-0 ID - Liu2020 ER - TY - JOUR AU - McGhie, T. K. AU - Harvey, P. AU - Su, J. AU - Anderson, N. PY - 2018 DA - 2018// TI - Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus JO - Clin Exp Rheumatol VL - 36 ID - McGhie2018 ER - TY - STD TI - Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 [published online ahead of print, 2020 Jul 23]. N Engl J Med. 2020:NEJMoa2019014. https://doi.org/10.1056/NEJMoa2019014. Online ahead of print. ID - ref40 ER - TY - JOUR AU - Mahévas, M. AU - Tran, V. T. AU - Roumier, M. PY - 2020 DA - 2020// TI - Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data [published correction appears in BMJ. 2020 Jun 18;369:m2328] JO - BMJ VL - 369 UR - https://doi.org/10.1136/bmj.m1844 DO - 10.1136/bmj.m1844 ID - Mahévas2020 ER - TY - STD TI - RECOVERY trial investigators. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19. https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19. Accessed 29 July 2020. UR - https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19 ID - ref42 ER - TY - JOUR AU - Wang, Y. AU - Zhang, D. AU - Du, G. PY - 2020 DA - 2020// TI - Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial [published correction appears in Lancet. 2020 May 30;395(10238):1694] JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)31022-9 DO - 10.1016/S0140-6736(20)31022-9 ID - Wang2020 ER - TY - JOUR AU - Shakoory, B. AU - Carcillo, J. A. AU - Chatham, W. W. PY - 2016 DA - 2016// TI - Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial JO - Crit Care Med VL - 44 UR - https://doi.org/10.1097/CCM.0000000000001402 DO - 10.1097/CCM.0000000000001402 ID - Shakoory2016 ER - TY - JOUR AU - Ramírez, J. AU - Cañete, J. D. PY - 2018 DA - 2018// TI - Anakinra for the treatment of rheumatoid arthritis: a safety evaluation JO - Expert Opin Drug Saf VL - 17 UR - https://doi.org/10.1080/14740338.2018.1486819 DO - 10.1080/14740338.2018.1486819 ID - Ramírez2018 ER - TY - JOUR AU - Jones, G. AU - Ding, C. PY - 2010 DA - 2010// TI - Tocilizumab: a review of its safety and efficacy in rheumatoid arthritis JO - Clin Med Insights Arthritis Musculoskelet Disord VL - 3 UR - https://doi.org/10.4137/CMAMD.S4864 DO - 10.4137/CMAMD.S4864 ID - Jones2010 ER - TY - JOUR AU - Geng, Z. AU - Yu, Y. AU - Hu, S. AU - Dong, L. PY - 2019 DA - 2019// TI - Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials JO - Clin Exp Rheumatol VL - 37 ID - Geng2019 ER - TY - STD TI - Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; published online March 3. ID - ref48 ER - TY - STD TI - ClinicalTrials.gov Identifier: https://clinicaltrials.gov/ct2/show/NCT04315480. UR - https://clinicaltrials.gov/ct2/show/NCT04315480 ID - ref49 ER - TY - JOUR AU - Sciascia, S. AU - Aprà, F. AU - Baffa, A. PY - 2020 DA - 2020// TI - Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 JO - Clin Exp Rheumatol VL - 38 ID - Sciascia2020 ER - TY - JOUR AU - Guaraldi, G. AU - Meschiari, M. AU - Cozzi-Lepri, A. PY - 2020 DA - 2020// TI - Tocilizumab in patients with severe COVID-19: a retrospective cohort study JO - Lancet Rheumatol. VL - 2 UR - https://doi.org/10.1016/S2665-9913(20)30173-9 DO - 10.1016/S2665-9913(20)30173-9 ID - Guaraldi2020 ER - TY - JOUR AU - Morena, V. AU - Milazzo, L. AU - Oreni, L. PY - 2020 DA - 2020// TI - Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan JO - Italy Eur J Intern Med VL - 76 UR - https://doi.org/10.1016/j.ejim.2020.05.011 DO - 10.1016/j.ejim.2020.05.011 ID - Morena2020 ER - TY - JOUR AU - Cavalli, G. AU - Luca, G. AU - Campochiaro, C. PY - 2020 DA - 2020// TI - Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study JO - Lancet Rheumatol VL - 2 UR - https://doi.org/10.1016/S2665-9913(20)30127-2 DO - 10.1016/S2665-9913(20)30127-2 ID - Cavalli2020 ER - TY - STD TI - World Health Organization. Novel Coronavirus (2019-nCoV) technical guidance: Patient management. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management. Accessed 02 Feb 2020. UR - https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management ID - ref54 ER - TY - STD TI - Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel coronavirus (2019-nCoV) infection, Updated February 12, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html. Accessed 14 Feb 2020. UR - https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html ID - ref55 ER - TY - STD TI - Bhimraj A, Morgan RL, Shumaker A, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. IDSA. Clin Infect Dis. 2020;ciaa478. https://doi.org/10.1093/cid/ciaa478. Online ahead of print. ID - ref56 ER - TY - STD TI - Alhazzani W, Moller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854–87. ID - ref57 ER - TY - STD TI - UK Government press release. World first coronavirus treatment approved for NHS use by government https://www.gov.uk/government/news/world-first-coronavirus-treatment-approved-for-nhs-use-by-government. Accessed 19 June 2020. UR - https://www.gov.uk/government/news/world-first-coronavirus-treatment-approved-for-nhs-use-by-government ID - ref58 ER - TY - JOUR AU - Lee, N. AU - Choi, K. W. AU - Chan, P. K. PY - 2010 DA - 2010// TI - Outcomes of adults hospitalised with severe influenza JO - Thorax VL - 65 UR - https://doi.org/10.1136/thx.2009.130799 DO - 10.1136/thx.2009.130799 ID - Lee2010 ER - TY - JOUR AU - McGeer, A. AU - Green, K. A. AU - Plevneshi, A. PY - 2007 DA - 2007// TI - Toronto invasive bacterial diseases network. Antivira therapy and outcomes of influenza requiring hospitalization in Ontario, Canada JO - Clin Infect Dis VL - 45 UR - https://doi.org/10.1086/523584 DO - 10.1086/523584 ID - McGeer2007 ER - TY - JOUR AU - Priori, S. G. AU - Schwartz, P. J. AU - Napolitano, C. PY - 2003 DA - 2003// TI - Risk stratification in the long-QT syndrome JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa022147 DO - 10.1056/NEJMoa022147 ID - Priori2003 ER - TY - JOUR AU - Mosholder, A. D. AU - Mathew, J. AU - Alexander, J. J. AU - Smith, H. AU - Nambiar, S. PY - 2013 DA - 2013// TI - Cardiovascular risks with azithromycin and other antibacterial drugs JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMp1302726 DO - 10.1056/NEJMp1302726 ID - Mosholder2013 ER - TY - JOUR AU - Svanström, H. AU - Pasternak, B. AU - Hviid, A. PY - 2013 DA - 2013// TI - Use of azithromycin and death from cardiovascular causes JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1300799 DO - 10.1056/NEJMoa1300799 ID - Svanström2013 ER - TY - JOUR AU - Ray, W. A. AU - Murray, K. T. AU - Hall, K. AU - Arbogast, P. G. AU - Stein, C. M. PY - 2012 DA - 2012// TI - Azithromycin and the risk of cardiovascular death JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1003833 DO - 10.1056/NEJMoa1003833 ID - Ray2012 ER - TY - JOUR AU - Lu, Z. K. AU - Yuan, J. AU - Li, M. PY - 2015 DA - 2015// TI - Cardiac risks associated with antibiotics: azithromycin and levofloxacin JO - Expert Opin Drug Saf VL - 14 UR - https://doi.org/10.1517/14740338.2015.989210 DO - 10.1517/14740338.2015.989210 ID - Lu2015 ER - TY - JOUR AU - Helms, J. AU - Tacquard, C. AU - Severac, F. PY - 2020 DA - 2020// TI - High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study JO - Intensive Care Med VL - 46 UR - https://doi.org/10.1007/s00134-020-06062-x DO - 10.1007/s00134-020-06062-x ID - Helms2020 ER - TY - STD TI - Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J. 2020;41(19):1858. ID - ref67 ER - TY - STD TI - Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [published online ahead of print, 2020 Apr 10]. Thromb Res. 2020;S0049–3848(20)30120–1. https://doi.org/10.1016/j.thromres.2020.04.013. ID - ref68 ER - TY - JOUR AU - Artifoni, M. AU - Danic, G. AU - Gautier, G. PY - 2020 DA - 2020// TI - Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors JO - J Thromb Thrombolysis VL - 50 UR - https://doi.org/10.1007/s11239-020-02146-z DO - 10.1007/s11239-020-02146-z ID - Artifoni2020 ER - TY - JOUR AU - Toplis, E. AU - Mortimore, G. PY - 2010 DA - 2010// TI - The diagnosis and management of pulmonary embolism JO - Aust Fam Physician VL - 39 ID - Toplis2010 ER - TY - JOUR AU - Conti, P. AU - Ronconi, G. AU - Caraffa, A. PY - 2020 DA - 2020// TI - Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies [published online ahead of print, 2020 Mar 14] JO - J Biol Regul Homeost Agents VL - 34 ID - Conti2020 ER - TY - STD TI - Cugno M, Meroni PL, Gualtierotti R, et al. Complement activation in patients with COVID-19: A novel therapeutic target [published online ahead of print, 2020 May 14]. J Allergy Clin Immunol. 2020;146(1):215–7. https://doi.org/10.1016/j.jaci.2020.05.006. ID - ref72 ER - TY - JOUR AU - Kiekkas, P. AU - Aretha, D. AU - Bakalis, N. AU - Karpouhtsi, I. AU - Marneras, C. AU - Baltopoulos, G. I. PY - 2013 DA - 2013// TI - Fever effects and treatment in critical care: literature review JO - Aust Crit Care VL - 26 UR - https://doi.org/10.1016/j.aucc.2012.10.004 DO - 10.1016/j.aucc.2012.10.004 ID - Kiekkas2013 ER - TY - JOUR AU - Launey, Y. AU - Nesseler, N. AU - Mallédant, Y. AU - Seguin, P. PY - 2011 DA - 2011// TI - Clinical review: fever in septic ICU patients--friend or foe? JO - Crit Care VL - 15 UR - https://doi.org/10.1186/cc10097 DO - 10.1186/cc10097 ID - Launey2011 ER - TY - STD TI - Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis [published online ahead of print, 2020 Mar 26]. Eur Respir J. 2020:2000547. https://doi.org/10.1183/13993003.00547-2020. ID - ref75 ER - TY - JOUR AU - Lu, R. AU - Zhao, X. AU - Li, J. AU - Niu, P. AU - Yang, B. AU - Wu, H. PY - 2020 DA - 2020// TI - Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30251-8 DO - 10.1016/S0140-6736(20)30251-8 ID - Lu2020 ER - TY - JOUR AU - Zhou, P. AU - Yang, X. L. AU - Wang, X. G. PY - 2020 DA - 2020// TI - A pneumonia outbreak associated with a new coronavirus of probable bat origin JO - Nature. VL - 579 UR - https://doi.org/10.1038/s41586-020-2012-7 DO - 10.1038/s41586-020-2012-7 ID - Zhou2020 ER - TY - BOOK AU - Kouhpayeh, S. PY - 2020 DA - 2020// TI - The molecular story of COVID-19; NAD+ depletion addresses all questions in this infection ID - Kouhpayeh2020 ER - TY - JOUR AU - Garin, N. AU - Felix, G. AU - Chuard, C. PY - 2016 DA - 2016// TI - Predictors and implications of early clinical stability in patients hospitalized for moderately severe community-acquired pneumonia JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0157350 DO - 10.1371/journal.pone.0157350 ID - Garin2016 ER - TY - JOUR AU - Halm, E. A. AU - Fine, M. J. AU - Marrie, T. J. AU - Coley, C. M. AU - Kapoor, W. N. AU - Obrosky, D. S. PY - 1998 DA - 1998// TI - Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines JO - JAMA VL - 279 UR - https://doi.org/10.1001/jama.279.18.1452 DO - 10.1001/jama.279.18.1452 ID - Halm1998 ER - TY - JOUR AU - Aliberti, S. AU - Zanaboni, A. M. AU - Wiemken, T. PY - 2013 DA - 2013// TI - Criteria for clinical stability in hospitalised patients with community-acquired pneumonia JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00100812 DO - 10.1183/09031936.00100812 ID - Aliberti2013 ER - TY - JOUR AU - Menéndez, R. AU - Torres, A. AU - Zalacaín, R. AU - Aspa, J. AU - Martín Villasclaras, J. J. AU - Borderías, L. PY - 2004 DA - 2004// TI - Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome JO - Thorax VL - 59 UR - https://doi.org/10.1136/thx.2003.017756 DO - 10.1136/thx.2003.017756 ID - Menéndez2004 ER - TY - JOUR AU - Chan, J. F. AU - Yuan, S. AU - Kok, K. H. PY - 2020 DA - 2020// TI - A familial cluster of pneumonia associated with the 2019 novel 180 coronavirus indicating person-to-person transmission: a study of a family cluster JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30154-9 DO - 10.1016/S0140-6736(20)30154-9 ID - Chan2020 ER - TY - JOUR AU - Li, Q. AU - Guan, X. AU - Wu, P. PY - 2020 DA - 2020// TI - Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMoa2001316 DO - 10.1056/NEJMoa2001316 ID - Li2020 ER - TY - JOUR AU - Zou, L. AU - Ruan, F. AU - Huang, M. PY - 2020 DA - 2020// TI - SARS-CoV-2 viral load in upper respiratory specimens of infected patients JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMc2001737 DO - 10.1056/NEJMc2001737 ID - Zou2020 ER - TY - STD TI - Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA. 2020. https://doi.org/10.1001/jama.2020.2648. ID - ref86 ER - TY - JOUR AU - Doremalen, N. AU - Bushmaker, T. AU - Morris, D. H. PY - 2020 DA - 2020// TI - Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMc2004973 DO - 10.1056/NEJMc2004973 ID - Doremalen2020 ER - TY - STD TI - Disposition of the Italian Minister of Health n. 5443. New indications and clarifications. http://www.trovanorme. salute.gov.it/norme/ Date last updated: 22 February 2020; date last accessed: 30 Mar 2020. UR - http://salute.gov.it/norme ID - ref88 ER - TY - JOUR PY - 2020 DA - 2020// TI - Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia JO - ZhonghuaJie He He Hu Xi Za Zhi VL - 17 ID - ref89 ER - TY - STD TI - World Health Organization. Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) Interim guidance. https://apps.who.int/iris/bitstream/handle/10665/331215/WHO-2019-nCovIPCPPE_use-2020.1-eng.pdf Date last updated: 27 February 2020; date last accessed: 30 Mar 2020. UR - https://apps.who.int/iris/bitstream/handle/10665/331215/WHO-2019-nCovIPCPPE_use-2020.1-eng.pdf ID - ref90 ER - TY - JOUR AU - Tran, K. AU - Cimon, K. AU - Severn, M. PY - 2012 DA - 2012// TI - Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0035797 DO - 10.1371/journal.pone.0035797 ID - Tran2012 ER - TY - JOUR PY - 2020 DA - 2020// TI - Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control JO - ZhonghuaJie He He Hu Xi Za Zhi VL - 43 ID - ref92 ER -